Literature DB >> 3724506

Isolation and characterization of apolipoprotein E.

S C Rall, K H Weisgraber, R W Mahley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3724506     DOI： 10.1016/0076-6879(86)28073-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  20 in total

1.  Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration.

Authors:  M Buttini; M Orth; S Bellosta; H Akeefe; R E Pitas; T Wyss-Coray; L Mucke; R W Mahley
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

2.  Apolipoprotein E forms stable complexes with recombinant Alzheimer's disease beta-amyloid precursor protein.

Authors:  C Haas; P Cazorla; C D Miguel; F Valdivieso; J Vázquez
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members.

Authors:  Jennifer M MacArthur; Joseph R Bishop; Kristin I Stanford; Lianchun Wang; André Bensadoun; Joseph L Witztum; Jeffrey D Esko
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

4.  Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice.

Authors:  B Zhu; D G Kuhel; D P Witte; D Y Hui
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

5.  Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles.

Authors:  Karita Haapasalo; Kok van Kessel; Eija Nissilä; Jari Metso; Tiira Johansson; Sini Miettinen; Markku Varjosalo; Juha Kirveskari; Pentti Kuusela; Angelika Chroni; Matti Jauhiainen; Jos van Strijp; T Sakari Jokiranta
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

6.  Transthyretin sequesters amyloid beta protein and prevents amyloid formation.

Authors:  A L Schwarzman; L Gregori; M P Vitek; S Lyubski; W J Strittmatter; J J Enghilde; R Bhasin; J Silverman; K H Weisgraber; P K Coyle
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

7.  Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice.

Authors:  S Bellosta; R W Mahley; D A Sanan; J Murata; D L Newland; J M Taylor; R E Pitas
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

8.  Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits.

Authors:  R W Mahley; K H Weisgraber; M M Hussain; B Greenman; M Fisher; T Vogel; M Gorecki
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

9.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease.

Authors:  W J Strittmatter; K H Weisgraber; D Y Huang; L M Dong; G S Salvesen; M Pericak-Vance; D Schmechel; A M Saunders; D Goldgaber; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

10.  Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; M Goedert; K H Weisgraber; L M Dong; R Jakes; D Y Huang; M Pericak-Vance; D Schmechel; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.